Literature DB >> 17712120

Impact of obesity on left ventricular mass and function in subjects with chronic volume overload.

Piercarlo Ballo1, Andrea Motto, Sergio Mondillo, Sergio A Faraguti.   

Abstract

OBJECTIVE: Previous studies evaluated the effect of obesity on left ventricular (LV) mass and systolic function in healthy subjects and in patients with coexistent chronic LV pressure overload due to hypertension, but no data exist regarding subjects with underlying volume overload. This study assessed the impact of overweight-obesity on LV mass and systolic function in patients with coexistent chronic LV volume overload. RESEARCH METHODS AND PROCEDURES: In 885 subjects with degenerative aortic regurgitation, a common cause of LV volume overload, LV mass, ejection fraction, and myocardial contractility were determined by echocardiography.
RESULTS: LV mass was greater in overweight (193.5 +/- 54.2 g) and further increased in obese subjects (208.4 +/- 63.6 g) in comparison with normal-weight patients (177.7 +/- 54.9 g) (p < 0.0001), and these differences were still evident after adjustment for LV workload, gender, and body size. Despite no differences in ejection fraction, LV myocardial contractility was lower in overweight (92.6 +/- 14.8%) and obese subjects (91.7 +/- 14.4%) than normal-weight individuals (95.6 +/- 16.0%) (p = 0.0058). The magnitudes of these effects were not different from those found in age-, gender-, and body size-matched controls, suggesting additive interaction, rather than synergistic, between overweight-obesity and the underlying condition of volume overload. Multivariate analysis showed that BMI independently predicted LV mass and that the negative effect on LV myocardial contractility was mediated by LV hypertrophy. DISCUSSION: Overweight and obesity are associated with LV hypertrophy and contractile impairment in patients with underlying chronic LV volume overload.

Entities:  

Mesh:

Year:  2007        PMID: 17712120     DOI: 10.1038/oby.2007.241

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  6 in total

1.  Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism.

Authors:  Daniel J Sassoon; Adam G Goodwill; Jillian N Noblet; Abass M Conteh; B Paul Herring; Jeanette N McClintick; Johnathan D Tune; Kieren J Mather
Journal:  Basic Res Cardiol       Date:  2016-05-27       Impact factor: 17.165

2.  Which measures of adiposity predict subsequent left ventricular geometry? Evidence from the Bogalusa Heart Study.

Authors:  T Hu; L Yao; J Gustat; W Chen; L Webber; L Bazzano
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-11-17       Impact factor: 4.222

3.  Left Ventricular Function Across the Spectrum of Body Mass Index in African Americans: The Jackson Heart Study.

Authors:  Vivek G Patel; Deepak K Gupta; James G Terry; Edmond K Kabagambe; Thomas J Wang; Aldolfo Correa; Michael Griswold; Herman Taylor; John Jeffrey Carr
Journal:  JACC Heart Fail       Date:  2017-03       Impact factor: 12.035

4.  Independent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: a meta-analysis.

Authors:  Kun Zhang; Feifei Huang; Jie Chen; Qingqing Cai; Tong Wang; Rong Zou; Zhiyi Zuo; Jingfeng Wang; Hui Huang
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

5.  Lung function and left ventricular hypertrophy in morbidly obese candidates for bariatric surgery.

Authors:  Paulo de Tarso Müller; Hamilton Domingos; Luiz Armando Pereira Patusco; Gabriel Victor Guimarães Rapello
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

6.  Abdominal obesity and structure and function of the heart in healthy male Koreans: The ARIRANG study.

Authors:  Jung-Woo Son; Joong Kyung Sung; Jun-Won Lee; Young Jin Youn; Min-Soo Ahn; Sung Gyun Ahn; Byung-Su Yoo; Seung-Hwan Lee; Junghan Yoon; Sang Baek Koh; Jang-Young Kim
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.